Zwiers Regulatory Consultancy is organising RA2day on April 7th 2017. During this afternoon event new talents and experienced professionals will present on topics that are relevant for today’s regulatory practice. In addition, the event allows meeting up with colleagues in the field.

The presentations on orphan drugs and advanced therapy medicinal products will emphasize on current challenges in developing and authorising these types of products. Clinical trials data publication, post-authorisation safety studies, educational materials and early access are certainly also hot topics in the regulatory field.

The set up of the event allows informal discussion on the subjects and networking. The small fee that is being requested will be largely used to the benefit of charity.

Zwiers Regulatory Consultancy provides regulatory and pharmacovigilance support throughout the entire drug and medical device lifecycle, including strategic advice, regulatory documents, training and staffing. The company is located in Pivot Park in Oss, The Netherlands.

More information: Karin Ruijtenbeek,, 06-10488548,